PDT Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Sell |
41,405
-55,029
| -57% | -$292K | 0.01% | 629 |
|
|
2025
Q1 | $855K | Buy |
+96,434
| New | +$855K | 0.06% | 415 |
|
|
2021
Q2 | – | Sell |
-11,760
| Closed | -$358K | – | 910 |
|
|
2021
Q1 | $358K | Sell |
11,760
-52,714
| -82% | -$1.6M | 0.03% | 572 |
|
|
2020
Q4 | $1.28M | Sell |
64,474
-60,975
| -49% | -$1.21M | 0.09% | 284 |
|
|
2020
Q3 | $1.64M | Buy |
+125,449
| New | +$1.64M | 0.11% | 239 |
|
|
2017
Q3 | – | Sell |
-328,200
| Closed | -$8.48M | – | 547 |
|
|
2017
Q2 | $8.48M | Buy |
+328,200
| New | +$8.48M | 0.34% | 106 |
|
|
2017
Q1 | – | Sell |
-222,056
| Closed | -$3.7M | – | 514 |
|
|
2016
Q4 | $3.7M | Buy |
222,056
+51,556
| +30% | +$860K | 0.24% | 175 |
|
|
2016
Q3 | $3.51M | Buy |
170,500
+31,000
| +22% | +$638K | 0.21% | 173 |
|
|
2016
Q2 | $4.27M | Hold |
139,500
| – | – | 0.34% | 136 |
|
|
2016
Q1 | $5.22M | Buy |
139,500
+59,300
| +74% | +$2.22M | 0.33% | 120 |
|
|
2015
Q4 | $3.46M | Buy |
80,200
+7,886
| +11% | +$340K | 0.47% | 80 |
|
|
2015
Q3 | $2.71M | Buy |
72,314
+23,672
| +49% | +$887K | 0.06% | 350 |
|
|
2015
Q2 | $1.65M | Buy |
+48,642
| New | +$1.65M | 0.04% | 505 |
|
|
2014
Q4 | – | Sell |
-28,214
| Closed | -$1.09M | – | 925 |
|
|
2014
Q3 | $1.09M | Sell |
28,214
-3,428
| -11% | -$132K | 0.03% | 610 |
|
|
2014
Q2 | $1.23M | Sell |
31,642
-2,914
| -8% | -$113K | 0.03% | 623 |
|
|
2014
Q1 | $1.18M | Buy |
+34,556
| New | +$1.18M | 0.03% | 625 |
|
|
2013
Q4 | – | Sell |
-430,743
| Closed | -$10.1M | – | 985 |
|
|
2013
Q3 | $10.1M | Buy |
430,743
+260,370
| +153% | +$6.12M | 0.27% | 66 |
|
|
2013
Q2 | $4.58M | Buy |
+170,373
| New | +$4.58M | 0.11% | 223 |
|